Our Team

Each Partner brings extensive industry knowledge, unrivaled relationships and substantial deal experience, resulting in a team of the industry's most sought after advisors

David M. Cohen

With more than 30 years of investment banking and private equity experience, David Cohen is a trusted advisor to Fortune 100 companies and leading private equity firms. Selected notable transactions in which Mr. Cohen has been a senior advisor include 21st Century Fox’s $85 billion sale to The Walt Disney Company and related separation of new Fox, Fortive’s separation of Vontier, Johnson Controls’ $16.5 billion merger with Tyco, Lorillard’s $27 billion sale to Reynolds American, Alcan's takeover defense from Alcoa and its ultimate $38 billion sale to Rio Tinto, News Corporation's separation of its publishing business from its entertainment operations, Clearwire's $14 billion sale to Sprint, General Electric's $3.8 billion sale of GE Advanced Materials to Apollo Management, Cendant's $20 billion reorganization plan, United Technologies’ $2 billion acquisition of Chubb plc, and Bain Capital’s $3 billion LBO of Sensata.

Prior to Centerview, Mr. Cohen spent more than 13 years at JP Morgan Chase & Co where his last position was serving as a Partner in JP Morgan Chase’s private equity group – One Equity Partners. Prior to OEP, Mr. Cohen held the positions of Co-Head of JP Morgan’s North American M&A Group and Global Head of the Industrials Group. Before joining JPMorgan, Mr. Cohen was Co-Head of the M&A Group of S.G. Warburg Inc., worked for Wasserstein Perella & Co. Inc. in both M&A and High Yield Financing, and for Bain & Company as a management consultant.

Mr. Cohen is currently a member of the Board of Overseers of Weill Cornell Medical College. He also is a former member of Duke University's Trinity College Board of Visitors and has served on the boards of NCO Group, Inc. and X-Rite Incorporated. Additionally, Mr. Cohen served on the Board of Governors of Baltusrol Golf Club as well as the Board of the First Tee Metropolitan New York. He earned a M.B.A. with Distinction from the Wharton School of Business and graduated Summa Cum Laude from Duke University with an A.B. in Economics.
Centerview Partners takes a “One Firm” approach to deliver unmatched intellectual capital and integrity to all of our clients. We have industry-leading expertise in:

Centerview is honored to partner with leading charitable organizations in active support of our charities:

  • Arts Connection
  • NY Cares
  • Bottomless Closet
Numab Therapeutics AG
Announced: Q2 2024
Value: $1.25 billion
Status: Pending

Lead financial advisor to Numab Therapeutics on its sale of NM-26, a bi-specific antibody, to Johnson & Johnson
View All
New York

Centerview Partners LLC

31 West 52nd Street

22nd Floor

New York, New York 10019

(212) 380-2650 | Tel
(212) 380-2651 | Fax

Centerview Partners UK LLP

1 Sherwood Street

6th Floor

London W1F 7BL

02074099700 | Tel
02074099704 | Fax

Centerview Partners France SCS

51 Avenue Hoche

Paris 75008

0180200620 | Tel
0180200621 | Fax
Menlo Park

Centerview Partners LLC

1302 El Camino Real

Suite 350

Menlo Park, California 94025

(650) 822-5800 | Tel
(650) 822-5801 | Fax
San Francisco

Centerview Partners LLC

555 California Street

Suite 4300

San Francisco, California 94104

(415) 400-0900 | Tel
(415) 400-0901 | Fax

Copyright © 2008 - 2024 Centerview Partners Holdings LP. All Rights Reserved. | Privacy and Other Notices

Centerview Partners LLC, member SIPC